ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 35 filers reported holding ASLAN PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $170,000 | -22.4% | 343,720 | +41.0% | 0.05% | -19.3% |
| Q1 2022 | $219,000 | -73.3% | 243,720 | -66.7% | 0.06% | -72.3% |
| Q4 2021 | $820,000 | -37.1% | 732,500 | 0.0% | 0.21% | -40.5% |
| Q3 2021 | $1,304,000 | -41.7% | 732,500 | +8.1% | 0.35% | -26.1% |
| Q2 2021 | $2,236,000 | -1.5% | 677,500 | 0.0% | 0.47% | -13.2% |
| Q1 2021 | $2,270,000 | +1284.1% | 677,500 | +687.0% | 0.54% | +917.0% |
| Q3 2020 | $164,000 | -4.7% | 86,082 | 0.0% | 0.05% | +6.0% |
| Q2 2020 | $172,000 | +95.5% | 86,082 | 0.0% | 0.05% | +35.1% |
| Q1 2020 | $88,000 | -63.2% | 86,082 | -26.9% | 0.04% | -54.9% |
| Q4 2019 | $239,000 | – | 117,682 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,017,971 | $2,066,000 | 0.49% |
| DAFNA Capital Management LLC | 117,682 | $239,000 | 0.08% |
| Temasek Holdings (Private) Ltd | 1,422,475 | $2,888,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 415,450 | $843,000 | 0.02% |
| Virtu Financial LLC | 54,386 | $110,000 | 0.01% |
| MARSHALL WACE, LLP | 96,095 | $195,000 | 0.00% |
| UBS Group AG | 150 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 2,151 | $4,000 | 0.00% |
| MORGAN STANLEY | 18,582 | $37,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 10,000 | $20,000 | 0.00% |